Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$814M |
| 2 |
NVIDIA
NVDA
|
+$448M |
| 3 |
Microsoft
MSFT
|
+$394M |
| 4 |
Apple
AAPL
|
+$368M |
| 5 |
Johnson & Johnson
JNJ
|
+$288M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$616M |
| 2 |
Tesla
TSLA
|
+$406M |
| 3 |
Palo Alto Networks
PANW
|
+$400M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$394M |
| 5 |
AT&T
T
|
+$389M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.96% |
| 2 | Technology | 19.64% |
| 3 | Consumer Staples | 10.59% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Communication Services | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
1
Novo Nordisk
NVO
$213B
| $2.03B | 2.53% |
48,362,142
-1,331,200
| -3% | -$51.6M |
|
2
VeriSign
VRSN
$23.9B
| $1.1B | 1.38% |
4,841,290
-27,024
| -0.6% | -$5.88M |
|
3
Zoom
ZM
$25.2B
| $1.03B | 1.29% |
2,662,863
+142,000
| +6% | +$47.3M |
|
|
4
NVIDIA
NVDA
$5.14T
| $929M | 1.16% |
46,431,720
+27,940,000
| +151% | +$448M |
|
|
5
Amazon
AMZN
$2.63T
| $897M | 1.12% |
5,213,100
+4,896,000
| +1,544% | +$814M |
|
6
Target
TGT
$62.6B
| $870M | 1.09% |
3,600,559
+14,500
| +0.4% | +$3.17M |
|
7
Atlassian
TEAM
$21.7B
| $846M | 1.06% |
3,293,360
-48,060
| -1% | -$11.3M |
|
8
Moderna
MRNA
$23B
| $749M | 0.94% |
3,188,454
+1,552,925
| +95% | +$278M |
|
9
Kroger
KR
$35.3B
| $679M | 0.85% |
17,731,571
+557,500
| +3% | +$21M |
|
10
Monster Beverage
MNST
$93.6B
| $656M | 0.82% |
14,355,120
-1,558,400
| -10% | -$73.1M |
|
11
Franco-Nevada
FNV
$41.3B
| $634M | 0.79% |
4,369,790
-467,600
| -10% | -$67.7M |
|
|
ALXN
12
DELISTED
Alexion Pharmaceuticals
ALXN
| $578M | 0.72% |
3,147,521
-180,600
| -5% | -$31M |
|
13
Domino's
DPZ
$10.6B
| $573M | 0.72% |
1,228,025
+291,600
| +31% | +$124M |
|
14
Molina Healthcare
MOH
$11.6B
| $569M | 0.71% |
2,248,465
-217,950
| -9% | -$54.8M |
|
|
15
Microsoft
MSFT
$2.9T
| $561M | 0.7% |
2,069,184
+1,549,000
| +298% | +$394M |
|
|
16
Apple
AAPL
$4.79T
| $559M | 0.7% |
4,078,632
+2,841,100
| +230% | +$368M |
|
17
United Therapeutics
UTHR
$26.2B
| $558M | 0.7% |
3,110,191
-97,400
| -3% | -$18.6M |
|
18
Hershey
HSY
$35B
| $556M | 0.69% |
3,192,466
-168,795
| -5% | -$28.4M |
|
|
ABMD
19
DELISTED
Abiomed Inc
ABMD
| $524M | 0.65% |
1,678,923
-101,200
| -6% | -$31M |
|
20
Vodafone
VOD
$35.7B
| $511M | 0.64% |
29,809,976
-2,500,100
| -8% | -$46.8M |
|
21
Bristol-Myers Squibb
BMY
$124B
| $488M | 0.61% |
7,305,925
+333,738
| +5% | +$21.8M |
|
|
22
Alphabet (Google) Class A
GOOGL
$4.17T
| $483M | 0.6% |
3,956,960
-330,000
| -8% | -$38.5M |
|
23
Herbalife
HLF
$1.26B
| $469M | 0.59% |
8,894,664
-140,100
| -2% | -$6.97M |
|
24
Biogen
BIIB
$29.2B
| $461M | 0.57% |
1,330,003
-608,159
| -31% | -$184M |
|
25
Vertex Pharmaceuticals
VRTX
$120B
| $459M | 0.57% |
2,277,284
-123,000
| -5% | -$25.7M |
|
Similar funds
Renaissance Technologies's Q2 2021 Portfolio in Review
As of Q2 2021, Renaissance Technologies held 3,960 positions worth $80.1B, down 0.34% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $5.63B in Q2 2021, closing 551 positions and reducing 1,699 holdings. Its most notable exit was AT&T, an estimated $389M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Caterpillar worth $227M.
- Renaissance Technologies's largest Q2 2021 buy was Caterpillar: 1,042,778 shares worth $227M.
- Renaissance Technologies added most to Amazon in Q2 2021, an estimated $814M increase.
- Renaissance Technologies's biggest Q2 2021 reduction was Baidu, cutting an estimated $616M.
- Renaissance Technologies fully exited AT&T in Q2 2021, selling an estimated $389M.
- Renaissance Technologies's ten largest holdings make up 12% of its $80.1B portfolio in Q2 2021.
- Renaissance Technologies opened 701 new positions and closed 551 in Q2 2021.
- Renaissance Technologies's portfolio value fell 0.34% quarter-over-quarter to $80.1B.
Based on Renaissance Technologies's 13F filing for Q2 2021, filed 13 Aug 2021.